Factors affecting the particle size distribution and rheology of brinzolamide ophthalmic suspensions.

导出 LinkOut

翻译打印收藏纠错

作者： Anh,Vo ^[1] ; Xin,Feng ^[2] ; Deval,Patel ^[1] ; Adil,Mohammad ^[2] ; Darby,Kozak ^[3] ; Stephanie,Choi ^[3] ; Muhammad,Ashraf ^[2] ; Xiaoming,Xu ^[4]

作者单位： Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA; Office of Research Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. ^[1] Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. ^[2] Office of Research Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. ^[3] Division of Product Quality Research, Office of Testing and Research, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: xiaoming.xu@fda.hhs.gov. ^[4]

关键词 Brinzolamide Milling Particle size Rheology Suspension